Clinical Trials Directory

Trials / Unknown

UnknownNCT02955056

Ankle Fractures Treated With Teriparatide

A Feasibility Study to Explore the Difference in Healing Time Between Teriparatide Treatment and Standard Care on Weber B Ankle Fractures in Older People

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
10 (estimated)
Sponsor
Nottingham University Hospitals NHS Trust · Academic / Other
Sex
All
Age
50 Years
Healthy volunteers
Not accepted

Summary

This is a single site feasibility trial to test whether daily administration of Teriparatide, in participants with Weber type B ankle fractures that are being conservatively managed, is superior to the standard care treatment with regard to the rate of healing.

Detailed description

Ankle fractures are common in older people, they are very disabling and require either a cast or a boot for treatment and the patients need to use crutches for balance. These fractures can lead to complications including non union or delayed union in addition to risks of clotting of the leg vessels (deep vein thrombosis) where these clots can dislodge and migrate to the lungs (pulmonary embolus) resulting in breathing difficulties and/or death. Also these fractures commonly result in patients needing a temporary period of residential care. Therefore, if the healing time can be reduced, there is a potential for large benefits for the patient and reduced care costs for health and social care services. Teriparatide hormone is one of the new medications used for treating osteoporosis(weak bones), and studies in the USA have reported that Teriparatide hormone treatment can accelerate bone fracture healing time in pelvic fractures. Other reports also support faster healing time when Teriparatide hormone is used. The investigators are carrying out this feasibility study with 10 participants, in order to provide the information that will prepare us for carrying out a definitive study in the future.

Conditions

Interventions

TypeNameDescription
DRUGForsteo20 micrograms/80 microlitres solution for injection in pre-filled pen

Timeline

Start date
2016-10-01
Primary completion
2017-10-01
Completion
2017-10-01
First posted
2016-11-04
Last updated
2016-11-04

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT02955056. Inclusion in this directory is not an endorsement.